Goro Takeda

Venture Partner

Goro Takeda joined Sofinnova Ventures in 2007 as a Kauffman Venture Fellow with a focus on identifying Life Science spin-out opportunities in Asia. Goro holds the honor of being the first person from Japan to be selected as a Kauffman Venture Fellow. He is also a co-founder of FinTech Global Capital, an early stage venture capital firm in Tokyo, where he currently serves as Managing Partner.

Before arriving at Sofinnova Ventures, Goro was the Deputy General Manager of NIF SMBC Ventures, a Japanese venture capital firm with $2 billion under management. Goro was responsible for life science investments across multiple geographic regions. Goro was involved with investments in biotechnology and specialty pharmaceutical companies including Arrow Therapeutics, Cyclacel Pharmaceuticals, and Orexigen Therapeutics. Prior to launching his career in venture capital, Goro spent nine years in the pharmaceutical industry, most recently as Corporate Officer of the U.S. subsidiary of Tanabe Pharmaceuticals. While in this position, Goro worked on global business development and marketing assignments.

Goro holds a Bachelor of Science in Chemistry from Waseda University and an M.B.A. from the Kellogg Graduate School at Northwestern University.